WHY HEMP OIL?
NOTE: Just to make sure we eliminate any confusion, let’s clarify with a few important definitions and distinctions.
Cannabinoids are a diverse group of at least 113 chemical compounds found in the cannabis plant. Specific cannabinoids have greatly varied activity and effects. The most widely known cannabinoid is tetrahydrocannabinol, or THC, which is the chemical in marijuana that creates the “high”. The second most widely known is cannabidiol, or CBD, which does not create any high and has the properties which are the subject of this Special Report.
Hemp, as a plant, has been used in dozens of ways ranging from making high-strength rope, to clothing, to medicines. Hemp oil is
made from pressing hemp seeds and, as you may have seen, is used in a variety of products, such as lotions and creams. CBD oil is the short-hand abbreviation for cannabidiol oil. Cannabidiol is a natural component of industrial hemp oil and, as mentioned above, is not psychoactive. There is no high.
Hemp seeds, the source of hemp oil, are rich in protein, polyunsaturated fatty acids, omega 6, omega 3, and insoluble fiber. They are considered a good source of tocopherols (vitamin E antioxidants). They are also high in essential fatty acids, such as omega 6 and omega 3, in a 3:1 ratio, which is a ratio used in our bodies and is considered beneficial for heart health.
Formal and ground-breaking research has studied the use of hemp oil consumed directly for its nutritional value. It has been used to support heart health, increased immunity, used in anti-aging skin creams, and for general anti-degenerative, anti-aging support. It has also been shown to have anti-inflammatory capabilities. All these benefits merit a further look as an adjunct to sleep support, especially the anti-inflammatory component, but there are other reasons that are even more significant. Those who claim, “there’s no hard evidence to support cannabinoid use”, or say, “There’s no medicinal value,” probably need to re-think their position.
The U.S. government itself recognizes the value of cannabinoids. Identified as Patent 6,630,507 (granted to the National Institute of Health in 2003), covers the use of non-psychoactive cannabinoids, as antioxidants and neuroprotectants, to protect the brain from damage or degeneration. Co-authored by Nobel Laureate Julius Axelrod, working with National Institute of Health scientists, the patent text reads (in part), “The cannabinoids are found to have particular application as neuroprotectants. Non-psychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they
Copyright 2018 Intellimaxx LLC. 8
avoid toxicity.” In fact, it was noted that there is basically no chance of overdosing.
By comparison, when a person smokes, snorts, or injects an opioid, the chemical enters their bloodstream and then affects the brain by attaching to opioid receptors creating the “high” but also reducing respiration. Death by opioid overdose is suffocation and all the natural protective reflexes to prevent this are suppressed by the drug.
Not only is CBD being used to lessen opioid withdrawal symptoms, but CBD does not suppress respiration, which is why there is no lethal overdose risk.